- Home
- SYBT vs QDEL Comparison
SYBT vs QDEL Comparison
Compare SYBT & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBT
- QDEL
- Stock Information
- Founded
- SYBT 1904
- QDEL 1979
- Country
- SYBT United States
- QDEL United States
- Employees
- SYBT N/A
- QDEL N/A
- Industry
- SYBT Major Banks
- QDEL Medical Specialities
- Sector
- SYBT Finance
- QDEL Health Care
- Exchange
- SYBT Nasdaq
- QDEL Nasdaq
- Market Cap
- SYBT 2.1B
- QDEL 2.1B
- IPO Year
- SYBT N/A
- QDEL N/A
- Fundamental
- Price
- SYBT $66.45
- QDEL $27.60
- Analyst Decision
- SYBT Hold
- QDEL Hold
- Analyst Count
- SYBT 3
- QDEL 6
- Target Price
- SYBT $83.67
- QDEL $39.00
- AVG Volume (30 Days)
- SYBT 111.2K
- QDEL 1.2M
- Earning Date
- SYBT 10-29-2025
- QDEL 11-05-2025
- Dividend Yield
- SYBT 1.93%
- QDEL N/A
- EPS Growth
- SYBT 26.14
- QDEL N/A
- EPS
- SYBT 4.58
- QDEL N/A
- Revenue
- SYBT $378,633,000.00
- QDEL $2,741,600,000.00
- Revenue This Year
- SYBT $16.82
- QDEL N/A
- Revenue Next Year
- SYBT $5.11
- QDEL $2.65
- P/E Ratio
- SYBT $14.50
- QDEL N/A
- Revenue Growth
- SYBT 14.11
- QDEL N/A
- 52 Week Low
- SYBT $60.75
- QDEL $22.05
- 52 Week High
- SYBT $83.83
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- SYBT 40.65
- QDEL 45.13
- Support Level
- SYBT $65.69
- QDEL $27.42
- Resistance Level
- SYBT $68.84
- QDEL $30.85
- Average True Range (ATR)
- SYBT 2.04
- QDEL 1.10
- MACD
- SYBT 0.16
- QDEL -0.11
- Stochastic Oscillator
- SYBT 28.64
- QDEL 39.48
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.